Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $3.58 $6.48 Friday, 10th May 2024 FATE stock ended at $4.08. This is 4.62% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 17.83% from a day low at $3.67 to a day high of $4.33.
90 days $3.58 $8.83
52 weeks $1.63 $8.83

Historical Fate Therapeutics prices

Date Open High Low Close Volume
Aug 11, 2016 $2.33 $2.38 $2.22 $2.38 179 500
Aug 10, 2016 $2.49 $2.55 $2.20 $2.32 308 600
Aug 09, 2016 $2.65 $2.65 $2.31 $2.51 626 000
Aug 08, 2016 $2.13 $2.64 $2.06 $2.59 1 859 300
Aug 05, 2016 $2.08 $2.14 $2.06 $2.11 150 100
Aug 04, 2016 $2.08 $2.09 $2.04 $2.08 137 400
Aug 03, 2016 $2.05 $2.14 $2.00 $2.06 209 700
Aug 02, 2016 $1.99 $2.06 $1.90 $2.05 140 300
Aug 01, 2016 $2.10 $2.16 $1.96 $1.99 206 300
Jul 29, 2016 $1.99 $2.12 $1.92 $2.07 525 300
Jul 28, 2016 $2.00 $2.49 $1.90 $1.98 3 194 100
Jul 27, 2016 $1.75 $1.92 $1.73 $1.87 244 100
Jul 26, 2016 $1.70 $1.75 $1.67 $1.73 89 700
Jul 25, 2016 $1.72 $1.75 $1.65 $1.68 103 400
Jul 22, 2016 $1.75 $1.75 $1.62 $1.70 109 800
Jul 21, 2016 $1.67 $1.74 $1.65 $1.67 105 300
Jul 20, 2016 $1.69 $1.72 $1.55 $1.69 287 500
Jul 19, 2016 $1.71 $1.76 $1.66 $1.67 122 900
Jul 18, 2016 $1.65 $1.77 $1.64 $1.72 200 300
Jul 15, 2016 $1.74 $1.92 $1.70 $1.79 180 500
Jul 14, 2016 $1.75 $1.77 $1.70 $1.76 115 600
Jul 13, 2016 $1.74 $1.76 $1.70 $1.73 102 300
Jul 12, 2016 $1.77 $1.80 $1.73 $1.74 94 800
Jul 11, 2016 $1.77 $1.80 $1.73 $1.75 102 100
Jul 08, 2016 $1.80 $1.80 $1.71 $1.77 127 500
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT